You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
A genetic fungal risk factor
Although a number of women experience recurrent vulvovaginal candidiasis (RVVC), it is not well understood why they are prone to frequent infections. In addition, antifungals used to treat isolated infections can be inadequate in the recurrent setting, heightening the need to understand the etiology of RVVC. Jaeger et al. found that a polymorphism in lectin SIGLEC15 associated with recurrent candidiasis in two independent patient cohorts. Stimulation with Candida albicans increased SIGLEC15 expression and altered T cell cytokine production in human peripheral blood mononuclear cells and in a mouse model of RVVC. This work suggests that the SIGLEC15 variant leads to an altered immune response in patients with RVVC.
- Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
This is an article distributed under the terms of the Science Journals Default License.
